Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases (Q35709696)

9 August 2017

0 references

1 reference

title

Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases (English)

1 reference

9 August 2017

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26206254%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

author name string

K W Brudvik

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26206254%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

L Li

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26206254%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

C Conrad

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26206254%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

T A Aloia

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26206254%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

J-N Vauthey

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26206254%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

language of work or name

English

0 references

publication date

21 July 2015

1 reference

British Journal of Surgery

9 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26206254%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26206254%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26206254%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

page(s)

1175-1183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26206254%20AND%20SRC:MED&resulttype=core&format=json

High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome

14 June 2020

cites work

1 reference

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases

21 January 2018

1 reference

Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system

21 January 2018

1 reference

Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients.

21 January 2018

1 reference

Conditional survival after surgical resection of colorectal liver metastasis: an international multi-institutional analysis of 949 patients

21 January 2018

1 reference

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

21 January 2018

1 reference

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

21 January 2018

1 reference

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

21 January 2018

1 reference

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

21 January 2018

1 reference

Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases

21 January 2018

1 reference

KRAS status and outcome of liver resection after neoadjuvant chemotherapy including bevacizumab.

21 January 2018

1 reference

RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases

21 January 2018

1 reference

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

KRAS mutation correlates with accelerated metastatic progression in patients with colorectal liver metastases

21 January 2018

1 reference

KRAS mutations in primary colorectal cancer tumors and related metastases: a potential role in prediction of lung metastasis

21 January 2018

1 reference

Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases

21 January 2018

1 reference

MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases.

21 January 2018

1 reference

BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy.

21 January 2018

1 reference

Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability.

21 January 2018

1 reference

KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases

21 January 2018

1 reference

Clinical impact of c-MET expression and genetic mutational status in colorectal cancer patients after liver resection.

21 January 2018

1 reference

Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells.

21 January 2018

1 reference

Activated K-ras is involved in regulation of integrin expression in human colon carcinoma cells

21 January 2018

1 reference

Epithelial-to-mesenchymal transition and oncogenic Ras expression in resistance to the protein kinase Cbeta inhibitor enzastaurin in colon cancer cells

21 January 2018

1 reference

Oncogenic KRAS provides a uniquely powerful and variable oncogenic contribution among RAS family members in the colonic epithelium

21 January 2018

1 reference

BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study

21 January 2018

1 reference

Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer.

21 January 2018

1 reference

KRAS as prognostic biomarker in metastatic colorectal cancer patients treated with bevacizumab: a pooled analysis of 12 published trials

21 January 2018

1 reference

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

21 January 2018

1 reference

KRAS and BRAF mutational status in primary colorectal tumors and related metastatic sites: biological and clinical implications

21 January 2018

1 reference

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients.

21 January 2018

1 reference

KRAS Mutation Is Associated with Lung Metastasis in Patients with Curatively Resected Colorectal Cancer

21 January 2018

1 reference

Comparative genomic analysis of primary versus metastatic colorectal carcinomas.

21 January 2018

1 reference

Somatic profiling of the epidermal growth factor receptor pathway in tumors from patients with advanced colorectal cancer treated with chemotherapy ± cetuximab

21 January 2018

1 reference

The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis

21 January 2018

1 reference

Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA.

21 January 2018

1 reference

Companion-diagnostic testing limited to KRAS codons 12 and 13 misses 17% of potentially relevant RAS mutations in colorectal cancer.

21 January 2018

1 reference

Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases.

21 January 2018

1 reference

Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases.

21 January 2018

1 reference

Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases.

21 January 2018

1 reference

Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases

21 January 2018

1 reference

Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases

21 January 2018

1 reference

Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.

21 January 2018

1 reference

RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy before resection of colorectal liver metastases.

21 January 2018

1 reference

KRAS mutations in primary tumours and post-FOLFOX metastatic lesions in cases of colorectal cancer

21 January 2018

1 reference

KRAS mutation in patients undergoing hepatic resection for colorectal liver metastasis: a biomarker of cancer biology or a byproduct of patient selection?

21 January 2018

1 reference

A Nomogram for Predicting Disease-specific Survival After Hepatic Resection for Metastatic Colorectal Cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/BJS.9870

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26206254%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

1 reference